1. Home
  2. SHOT vs COEP Comparison

SHOT vs COEP Comparison

Compare SHOT & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHOT
  • COEP
  • Stock Information
  • Founded
  • SHOT 2018
  • COEP 2017
  • Country
  • SHOT United States
  • COEP United States
  • Employees
  • SHOT N/A
  • COEP N/A
  • Industry
  • SHOT Biotechnology: Pharmaceutical Preparations
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SHOT Health Care
  • COEP Health Care
  • Exchange
  • SHOT Nasdaq
  • COEP Nasdaq
  • Market Cap
  • SHOT 31.4M
  • COEP 32.4M
  • IPO Year
  • SHOT 2020
  • COEP N/A
  • Fundamental
  • Price
  • SHOT $0.47
  • COEP $12.31
  • Analyst Decision
  • SHOT
  • COEP
  • Analyst Count
  • SHOT 0
  • COEP 0
  • Target Price
  • SHOT N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • SHOT 669.4K
  • COEP 121.3K
  • Earning Date
  • SHOT 03-31-2025
  • COEP 03-25-2025
  • Dividend Yield
  • SHOT N/A
  • COEP N/A
  • EPS Growth
  • SHOT N/A
  • COEP N/A
  • EPS
  • SHOT N/A
  • COEP N/A
  • Revenue
  • SHOT $652,495.00
  • COEP N/A
  • Revenue This Year
  • SHOT N/A
  • COEP N/A
  • Revenue Next Year
  • SHOT N/A
  • COEP N/A
  • P/E Ratio
  • SHOT N/A
  • COEP N/A
  • Revenue Growth
  • SHOT 68.01
  • COEP N/A
  • 52 Week Low
  • SHOT $0.45
  • COEP $2.31
  • 52 Week High
  • SHOT $3.07
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • SHOT 36.56
  • COEP 62.60
  • Support Level
  • SHOT $0.45
  • COEP $8.65
  • Resistance Level
  • SHOT $0.58
  • COEP $13.70
  • Average True Range (ATR)
  • SHOT 0.05
  • COEP 1.89
  • MACD
  • SHOT 0.01
  • COEP -0.21
  • Stochastic Oscillator
  • SHOT 9.45
  • COEP 72.48

About SHOT Safety Shot Inc.

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: